Hoth Therapeutics Secures Japanese Patent for HT-KIT Platform Targeting Mast Cell Diseases
June 12, 2025
Protection through 2039, ensuring long-term commercial exclusivity Hoth Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies, announced that they have obtained Japan Country Patent No.